What is the CVR number of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S?

EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S is registered with CVR / Virk under CVR 29428689.

What is the revenue of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S?

EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S reported revenue of DKK 65M in 2024.

EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S employs 98 people as of the latest annual report.

John Birger Engelhardt is Chief Executive Officer of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S, in role since 2006.

Svend Aage Linde chairs the board of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S, in role since 2006.

EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S's registered address is Smedeskovvej 38.

A/SActive

CVR 29428689Smedeskovvej 38, 8464 GaltenTechnical testing and analysis · NACE 7120Est. 200698 employees

Actively employed in the business

Name	Role	Member since
Current (2)
JR Jan Rando Chief Executive Officer	Chief Executive Officer	2018
NS Nadja Sun Wissing Deputy	Deputy	2025
Former (3)
JB John Birger Engelhardt Chief Executive Officer	Chief Executive Officer	2006 – 2007
JK Jacob Klinge Jacobsen Chief Executive Officer	Chief Executive Officer	2007 – 2018
AJ Anette Jeppesen Deputy	Deputy	2008 – 2013

Non-executive oversight

Name	Role	Member since
Current (4)
SA Svend Aage Linde	Chairman	2006
JS Jacob Sickmann Ransborg	Board of Directors	2025
SH Stina Hansen	Board of Directors	2020
MA Mette Aaby Kramhöft	Board of Directors	2026
Former (11)
MT Michael Timm	Board of Directors	2014 – 2015
JA Jeppe Andersen Jacomo	Board of Directors	2025 – 2026
SH Steen Høpfner	Board of Directors	2007 – 2020
LØ Lene Østerby	Board of Directors	2007 – 2008
KK Karsten Krogh Jørgensen	Board of Directors	2006 – 2012
LC Lars Christian Caspersen	Board of Directors	2009 – 2015
SP Stefánia Pcolová	Board of Directors	2018 – 2025
CD Christina Daugbjerg Roden Nielsen	Board of Directors	2016 – 2020
HS Henning Stensgaard Jensen	Board of Directors	2006 – 2009
TG Thomas Gjelsnes	Board of Directors	2015 – 2018
OM Ole Møller	Board of Directors	2006 – 2011

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Eurofins BioPharma Product Testing Denmark Holding A/S	Company	100%	100%	2016
Eurofins Pharma Services LUX Holding SARL	Individual	100%	100%	2008

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.